Effect of induced hypertension with angiotensin II infusion on biodistribution of 111in-labeled monoclonal antibody

Nuclear Medicine and Biology

Volumn 23, Issue 2, 1996, Pages 137-140

  Kinuya, Seigo ^a   Yokoyama, Kunihiko ^a   Konishi, Shota ^a   Tonami, Norihisa ^a   Hisada, Kinichi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

111In labeled monoclonal antibody; Angiotensin II; Induced hypertension; Tumor targeting

Indexed keywords

ANGIOTENSIN; MONOCLONAL ANTIBODY IN 111; TECHNETIUM 99M; THALLIUM 201;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTENSION; MOUSE; PHARMACOKINETICS; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

ANGIOTENSIN II; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; INDIUM RADIOISOTOPES; INFUSIONS, INTRAVENOUS; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; RATS; SERUM ALBUMIN; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0029866585     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02040-3     Document Type: Article

References (23)

1. Abe I., Hori K., Saito S., Tanda S., Li Y. and Suzuki M. (1988) Increased intratumor concentration of fluorescein-isothiocyanato-labeled neocarzinostatin in rats under angiotensin-induced hypertension. Jpn. J. Cancer Res. (Gann) 79, 874-879.
2. 201Tl in tumor bearing animals and inflammatory lesion induced animals. Eur. J. Nucl. Med. 12, 567-572.
3. Baba T. and Taniguchi S. (1987) Improvements of angiotensin II hypertension cancer chemotherapy. Jpn. J. Cancer Chemother. 14, 971-977 (in Japanese).
4. Caulser C., Macapinlac H., Healey J., Ghavini F., Meyers P., Wollner N., Kalaigian J., Kostakoglu J., Abdel-Dayem H. M., Yeh S. D. J. and Larson S. M. (1992) The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin. Nucl. Med. 17, 565-572.
5. Douglas W. W. (1980) Polypeptides-angiotensin, plasma kinins, and others. In The pharmacological basis of therapeutics (Edited by Gilman A. G., Goodman L. S. and Gilman A.), pp. 647-667. Macmillan, New York.
6. Gridley D. S., Ewart K. L., Cao J. D. and Stickney D. R. (1990) Enhancement of monoclonal antibody uptake in human colon xenografts following irradiation. Cancer Res. 50, 159-163.
7. 201Tl-chloride. Eur. J. Nucl. Med. 3, 81-86.
8. Kalofons H., Rowlinson G. and Epenetos A. A. (1990) Enhancement of monoclonal antibody uptake in human tumor xenografts following irradiation. Cancer Res. 50, 159-163.
9. LeBerthon B., Khawli L. A., Miller G. K., Charak B. S., Mazumder A. and Epstein A. L. (1991) Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate. Cancer Res. 51, 2694-2698.
10. 201Tl scintigraphy. J. Juzen Med. Soc. 103, 453-464 (in Japanese).
11. Ong G. L. and Mattes M. J. (1989) Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res. 49, 4264-4273.
12. Paik C. H., Ebbert M. A., Murphy P. R., Lassman C. R., Reba R. C., Eckelman W. C., Pak K. Y., Powe J., Steplewski Z. and Koplowski H. (1983) Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. J. Nucl. Med. 24, 1158-1163.
13. Sands H., Jones P. L., Shah S. A., Palme D., Vessella R. L. and Gallagher B. M. (1988) Correlation of vascular permeability nd blood flow with monoclonal antibody uptake by human clouser and renal cell xenografts. Cancer Res. 48, 188-193.
14. Sato H., Hoshi M. and Wakui A. (1986) Clinical study of angiotensin-induced hypertension chemotherapy (1HC). Jap. J. Cancer Chemother. 13, 1439-1447 (in Japanese).
15. Schlom J., Hand P. H., Greiner J. W., Colcher D., Shrivastav S., Carrasquillo J. A., Reynolds J. C., Larson S. M. and Raubitschek A. (1990) Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting. Cancer Res. (suppl.) 50, 820s-827s.
16. Sehweil A., El-Sayed M., Ziada G., Al-Huda F., Mobarak L., Omar Y. T., Abdel-Dayem H. M. and McKillop J. H. (1986) Thallium-201 kinetics in malignant tumors. J. Nucl. Med. 27, 1033 (Abstract).
17. 201Tl uptake in tumors. Eur. J. Nucl. Med. 15, 376-379.
18. Shultz K. R., Badger C. C., Dombi G. W., Greenberg P. D. and Bernstein I. D. (1992) Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma. J. Natl. Cancer Inst. 84, 109-113.
19. 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II) biodistribution, metabolism and excretion in vivo. Jpn. J. Nucl. Med. (Kakuigaku) 31, 473-487 (in Japanese).
20. Suzuki M., Hori K., Abe I., Saito S. and Sato H. (1981) A new approach of cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J. Natl. Cancer Inst. 67, 663-669.
21. Wakui A. and Sato H. (1989) Induced hypertension chemotherapy by angiotensin II for solid tumor. Nippon-Rinsho 17, 564-569 (in Japanese).
22. Weinstein J. N. and van Osdol W. (1992) Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier." Cancer Res. (suppl.) 52, 2747s-2751s.
23. Winchell H. S. (1976) Mechanisms for localization of radiopharmaceuticals in neoplasms. Semin. Nucl. Med. 6, 371-396.